share_log

Eton Pharmaceutical | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Opaleye Management, Inc.(9.84%)

Eton Pharmaceutical | SC 13G/A:超過5%持股股東披露文件(修正)-Opaleye Management, Inc.(9.84%)

美股SEC公告 ·  02/09 16:13
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息